Self-experimentation reports: Thousands of individuals using peptides for injuries sharing experiences online (Reddit, forums, social media)
Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation
GLP-1 receptor agonists were originally approved for the treatment of type 2 diabetes, though given the prevalence of GLP-1 receptors in various peripheral tissues, more recent studies have started to look at additional etiologies for which GLP-1 agonists could be a feasible therapeutic option, including MASLD
[Google Scholar] 23.Dhurandhar E.J., Maki K.C., Dhurandhar N.V., Kyle T.K., Yurkow S., Hawkins M.A., Agley J., Ho E.H., Cheskin L.J., Sorensen T.I., Wang X.R., Allison D.B
Beyond appetite suppression, semaglutide improves metabolic efficiency by enhancing insulin secretion and reducing liver fat accumulation
Long-term treatment obviously incurs higher total costs